57 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
Adaptimmune CEO. “We are also announcing changes to our Executive Team. The role of manufacturing and supply chain in meeting our obligations … as Chief Patient Supply Officer to further build our state-of-the-art manufacturing and supply chain organization. We are also announcing that Rafael
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for Adaptimmune or TCR2’s product … and their impact on Adaptimmune’s and TCR2’s respective businesses, operations, supply chain, patient enrollment and retention, preclinical and clinical trials
425
TCRR
Tcr2 Therapeutics Inc
30 May 23
Business combination disclosure
4:21pm
of Adaptimmune’s or TCR2’s patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for Adaptimmune … health crises and their impact on Adaptimmune’s and TCR2’s respective businesses, operations, supply chain, patient enrollment and retention
8-K
ADAP
Adaptimmune Therapeutics Plc
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
of the supply chain for raw materials or manufacturing for Adaptimmune or TCR2’s product candidates, the nature, timing, cost and possible success and therapeutic … , operations, supply chain, patient enrollment and retention, preclinical and clinical trials, strategy, goals and anticipated milestones. While the foregoing
8-K
EX-99.1
jpos6 tq45
6 Mar 24
Adaptimmune Reports Q4 /Full Year 2023 Financial Results and Business Updates
7:05am
8-K
EX-99.1
y5y n1zgsjjvi6ngpa
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
icz9u59fv6s 91vqkt3j
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
8-K
EX-99.1
uole5ccihsi d7uu
1 Aug 19
Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update
7:23am
425
yjl9tdnb qwk2idqqmic
22 May 23
Business combination disclosure
7:01am
8-K
6airvaw5gyyghu
22 May 23
Other Events
6:59am